Intrinsic Value of S&P & Nasdaq Contact Us

Lumos Pharma, Inc. LUMO

NASDAQ Global Market

SharesGrow Score
54/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$16.50
+280.2%

Lumos Pharma, Inc. (LUMO) current share price is $4.34. The gold spot price is $4,825.20 per troy ounce. Using the formula: LUMO in gold = $4.34 × 31.1035 ÷ $4,825.20 = 0.0280 grams of gold per share.

The Real Wealth Growth Rate measures the Compound Annual Growth Rate (CAGR) of LUMO when denominated in gold. A positive rate means the stock has outperformed gold as a store of value, while a negative rate indicates gold has been a better wealth preserver than holding LUMO shares over the measured period.

LUMO in US Dollars
Gold in US Dollars
LUMO in Gold (grams per share)

Real Wealth Growth Rate

LUMO
Computing…

"Real Wealth Growth Rate" measures the annualised compound growth rate (CAGR) of a stock when priced in gold — hard money that cannot be printed. A positive value means genuine wealth creation. A negative value means purchasing power is shrinking, even if the dollar price rises.

Step 1 — Express share price in grams of gold
$$\text{LUMO}_{\text{gold}}(t) = \frac{P_{\text{LUMO}}(t) \times 31.1035}{P_{\text{gold}}(t)}$$
$P_\text{LUMO}$ = stock price in USD, $P_\text{gold}$ = gold spot in USD/troy oz, $31.1035$ = grams per troy ounce.
Step 2 — Real Wealth Growth Rate (CAGR in gold terms)
$$\text{Real Wealth Growth Rate} = \left(\frac{\text{LUMO}_{\text{gold}}^{(T)}}{\text{LUMO}_{\text{gold}}^{(0)}}\right)^{\!\frac{1}{T}} - 1$$
$\text{LUMO}_\text{gold}^{(0)}$ = initial gold-price, $\text{LUMO}_\text{gold}^{(T)}$ = current gold-price, $T$ = number of years. A positive result means the stock outpaces gold.

Real Wealth Growth Rate Rankings — 20 Years

Computing…

People Also View

ERAS
ERAS
Erasca, Inc.
$17.85
+9.44%
FBRX
FBRX
Forte Biosciences, Inc.
$32.42
+5.95%
ELYM
ELYM
Eliem Therapeutics, Inc.
$5.11
-0.97%
RZLT
RZLT
Rezolute, Inc.
$3.56
-1.36%
STTK
STTK
Shattuck Labs, Inc.
$6.78
+0.15%
IPSC
IPSC
Century Therapeutics, Inc.
$2.37
+4.41%
THRX
THRX
Theseus Pharmaceuticals, Inc.
$4.07
+0.12%
PRDS
PRDS
Pardes Biosciences, Inc.
$2.18
+0.93%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message